Ian Rhodes's Net Worth
-$462 Thousand
Who is Ian Rhodes?
Ian Rhodes does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include GlyEco, Inc., Akers Biosciences, Inc., and COMPETITIVE TECHNOLOGIES INC.
SEC CIK
Ian Rhodes's CIK is 0001612365
Past Insider Trading and Trends
2017 was Ian Rhodes's most active year for acquiring shares with 15 total transactions. Ian Rhodes's most active month to acquire stocks was the month of June. 2016 saw Ian Rhodes paying a total of $326,590.72 for 3,419,657 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GlyEco, Inc. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +41.28% | 2.23K |
$5.38 | $12,013.54 | 7.64K |
Jul 11
| |||
Form 4
| +47.11% | 2.23K |
$5.38 | $12,013.54 | 6.97K |
Jul 11
| |||
Form 4
| +12.73% | 66.92K |
$0.09 | $5,955.52 | 592.53K |
Dec 12 - Jan 4
| |||
Form 4
| +6.80% | 33.46K |
$0.09 | $2,977.76 | 525.61K |
Oct 31
| |||
Form 4
| +8.74% | 39.54K |
$0.08 | $3,024.96 | 492.16K |
Oct 2
| |||
Form 4
| +9.57% | 39.54K |
$0.08 | $3,024.96 | 452.61K |
Sep 1
| |||
Form 4
| +338.01% | 819.68K |
$0.08 | $65,455.77 | 1.06M |
Jul 31 - Aug 10
| |||
Form 4
| +8.99% | 20K |
$0.10 | $2,000.00 | 242.5K |
Jun 6
| |||
Form 4
| +9.88% | 20K |
$0.10 | $2,000.00 | 222.5K |
Apr 30
| |||
Form 4
| +8.97% | 16.67K |
$0.12 | $2,000.04 | 202.5K |
Mar 31
| |||
Form 4
| +2.43% | 80K |
$0.13 | $10,400.00 | 3.37M |
Feb 13
| |||
Form 4
| +0.49% | 16.67K |
$0.12 | $2,000.04 | 3.39M |
Feb 28
| |||
Form 4
| +2.43% | 80K |
$0.13 | $10,000.00 | 3.37M |
Feb 10
| |||
Form 4
| +44.72% | 1.02M |
$0.10 | $102,000.04 | 3.29M |
Dec 30 - Jan 31
| |||
Form 4
| +0.44% | 10K |
$0.10 | $1,000.00 | 2.27M |
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 27
| |||
Form 4
| +0.44% | 10K |
$0.10 | $1,000.00 | 2.26M |
Nov 30
| |||
Form 4
| +0.45% | 10K |
$0.10 | $1,000.00 | 2.25M |
Nov 1
| |||
Form 4
| +0.19% | 4.17K |
$0.12 | $500.04 | 2.24M |
Sep 30
| |||
Form 4
| +0.19% | 4.17K |
$0.12 | $500.04 | 2.24M |
Sep 1
| |||
Form 4
| +0.19% | 4.17K |
$0.12 | $500.04 | 2.24M |
Aug 1
| |||
Form 4
| +0.45% | 10K |
$0.10 | $1,000.00 | 2.23M |
Jul 5
| |||
Form 4
| +0.45% | 10K |
$0.10 | $1,000.00 | 2.22M |
Jun 1
| |||
Form 4
| +0.45% | 10K |
$0.10 | $1,000.00 | 2.21M |
May 2
| |||
Form 4
|
∞
| 2.2M |
$0.10 | $220,090.60 | 2.2M |
Mar 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Akers Biosciences, Inc. (MYMD) Snapshot price: $0.138
Interim CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
COMPETITIVE TECHNOLOGIES INC No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |